JUM etoc signup
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vergani, P.
Right arrow Articles by Ghidini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vergani, P.
Right arrow Articles by Ghidini, A.

Journal of Ultrasound in Medicine, Vol 18, Issue 7 469-473, Copyright © 1999 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

Best second trimester sonographic markers for the detection of trisomy 21

P. Vergani, A. Locatelli, M. G. Piccoli, P. Ceruti, E. Mariani, J. C. Pezzullo and A. Ghidini
Divisione di Ostetricia e Ginecologia, Istituto di Scienze Biomediche San Gerardo, Monza, Italy.

We analyzed all genetic sonograms obtained during a 6 year period to establish the independent ability of the following sonographic markers of aneuploidy in the diagnosis of trisomy 21: structural anomalies, cardiac abnormalities, nuchal fold thickness of 6 mm or greater, bowel echogenicity, choroid plexus cysts, and renal pyelectasis. With the exception of bowel echogenicity and choroid plexus cysts, the sonographic markers were more common in trisomy 21 than euploid fetuses (all P < 0.001). Logistic regression analysis demonstrated that cardiac anomalies (odds ratio = 255; 95% confidence interval, 25, 2592), other structural anomalies (odds ratio = 25; 95% confidence interval, 6, 97), and nuchal fold thickness of 6 mm or greater (odds ratio = 13; 95% confidence interval, 3, 50) were the only independent predictors of trisomy 21. The false-positive rate and sensitivity were 5.3% (48 of 898) and 59.2% (13 of 22), respectively, when any of the sonographic markers significant at univariate analysis was considered, and 3.1% (28 of 898) and 54.5% (12 of 22), respectively, when any of the predictors at multivariate analysis was present. Because a considerable overlap of sonographic markers exists among trisomy 21 fetuses, use of those that are not independent predictors leads to an increase in false-positive rate without a gain in sensitivity.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
B. Bromley, E. Lieberman, T. D. Shipp, and B. R. Benacerraf
The Genetic Sonogram: A Method of Risk Assessment for Down Syndrome in the Second Trimester
J. Ultrasound Med., October 1, 2002; 21(10): 1087 - 1096.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Smith-Bindman, W. Hosmer, V. A. Feldstein, J. J. Deeks, and J. D. Goldberg
Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
JAMA, February 28, 2001; 285(8): 1044 - 1055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Institute of Ultrasound in Medicine.